Application Sponsors
| ANDA 202288 | MYLAN PHARMS INC | |
Marketing Status
Application Products
| 001 | TABLET, EXTENDED RELEASE;ORAL | 300MG | 0 | LITHIUM CARBONATE | LITHIUM CARBONATE |
FDA Submissions
| ORIG | 1 | AP | 2012-06-29 | |
| LABELING; Labeling | SUPPL | 3 | AP | 2020-02-14 | STANDARD |
| LABELING; Labeling | SUPPL | 4 | AP | 2020-02-14 | STANDARD |
| LABELING; Labeling | SUPPL | 5 | AP | 2020-02-14 | STANDARD |
| LABELING; Labeling | SUPPL | 6 | AP | 2020-07-13 | STANDARD |
Submissions Property Types
| ORIG | 1 | Null | 7 |
| SUPPL | 3 | Null | 7 |
| SUPPL | 4 | Null | 15 |
| SUPPL | 5 | Null | 15 |
| SUPPL | 6 | Null | 15 |
TE Codes
CDER Filings
MYLAN PHARMS INC
cder:Array
(
[0] => Array
(
[ApplNo] => 202288
[companyName] => MYLAN PHARMS INC
[docInserts] => ["",""]
[products] => [{"drugName":"LITHIUM CARBONATE","activeIngredients":"LITHIUM CARBONATE","strength":"300MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"06\/29\/2012","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] => [{"actionDate":"07\/13\/2020","submission":"SUPPL-6","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"02\/14\/2020","submission":"SUPPL-5","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"02\/14\/2020","submission":"SUPPL-4","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"02\/14\/2020","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2020-07-13
)
)